— Know what they know.
Not Investment Advice
Also trades as: XTRX.CN (CNQ) · $vol 0M

XTXXF OTC

Adastra Holdings Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -30.0% 1Y: -44.9% 3Y: -99.7% 5Y: -99.9%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 40 · $39179 mcap · 6M float · 0.0015% daily turnover · Short 94% of daily vol

Income Trends

Revenue
$25M +11.8% ▲
Gross Profit
$9M +24.9% ▲
Operating Income
-$972K +45.8% ▲
Net Income
-$13M -273.4% ▼
EPS (Diluted)
$-2.36 -3628.3% ▼
EBITDA
-$11M -681.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$2M$6M$13M$22M$25M
YoY Growth+0.0%+125.2%+136.2%+67.1%+11.8%
Cost of Revenue$2M$4M$7M$15M$16M
Gross Profit$786K$2M$6M$7M$9M
Gross Margin31.4%34.5%46.0%31.6%35.3%
R&D Expenses$182K$89K$0$0$0
SG&A Expenses$8M$4M$6M$8M$8M
Operating Expenses$8M$4M$7M$9M$10M
Operating Income-$7M-$2M-$800K-$2M-$972K
Operating Margin-286.5%-42.5%-6.0%-8.1%-3.9%
Interest Expense$458K$277K$344K$1M$1M
Income Before Tax-$8M-$3M-$4M-$4M-$14M
Tax Expense$0-$15K-$56K-$317K-$593K
Net Income-$8M-$3M-$4M-$4M-$13M
Net Margin-304.7%-48.9%-32.2%-16.0%-53.3%
EPS (Diluted)$-0.19$-0.05$-0.07$-0.06$-2.36
EBITDA-$7M-$1M$560K-$1M-$11M
Shares Outstanding40M50M59M56M6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms